共 25 条
- [25] Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetese DIABETES OBESITY & METABOLISM, 2017, 19 (06): : 831 - 841